These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1992185)

  • 41. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
    Iwasaki Y; Mimuro M; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Neuropathology; 2008 Feb; 28(1):51-61. PubMed ID: 18181835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human pituitary growth hormone and Creutzfeldt-Jakob disease.
    Preece M
    Horm Res; 1993; 39(3-4):95-8. PubMed ID: 8262483
    [No Abstract]   [Full Text] [Related]  

  • 44. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.
    Holman RC; Khan AS; Belay ED; Schonberger LB
    Emerg Infect Dis; 1996; 2(4):333-7. PubMed ID: 8969250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Infectious prion disease: CJD with dura mater transplantation].
    Sato T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):870-2. PubMed ID: 15152489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of Creutzfeldt-Jakob disease following cataract surgery: sporadic versus iatrogenic cause.
    Gnanajothy R; Umashanker D; Vega MC; Wu BJ
    Conn Med; 2013; 77(6):335-7. PubMed ID: 23923250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iatrogenic Creutzfeldt-Jakob disease at the millennium.
    Brown P; Preece M; Brandel JP; Sato T; McShane L; Zerr I; Fletcher A; Will RG; Pocchiari M; Cashman NR; d'Aignaux JH; Cervenáková L; Fradkin J; Schonberger LB; Collins SJ
    Neurology; 2000 Oct; 55(8):1075-81. PubMed ID: 11071481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P; Brandel JP; Preece M; Sato T
    Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Creutzfeldt-Jakob Disease: In-hospital demographics report of national data in the United States from 2016 and review of a rapidly-progressive case.
    Kotkowski E; Cabot JH; Lacci JV; Payne DH; Cavazos JE; Romero RS; Seifi A
    Clin Neurol Neurosurg; 2020 Oct; 197():106103. PubMed ID: 32717558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
    Lewis AM; Yu M; DeArmond SJ; Dillon WP; Miller BL; Geschwind MD
    Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Creutzfeldt-Jakob disease.
    de Villemeur TB
    Handb Clin Neurol; 2013; 112():1191-3. PubMed ID: 23622328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.
    Holmes SJ; Ironside JW; Shalet SM
    J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):333-5. PubMed ID: 8609514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
    Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
    Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society, May 1985.
    J Pediatr; 1985 Jul; 107(1):10-2. PubMed ID: 3891943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Creutzfeldt-Jakob disease in Austria].
    Hainfellner JA; Jellinger K; Diringer H; Guentchev M; Kleinert R; Pilz P; Maier H; Budka H
    Wien Klin Wochenschr; 1996 Dec; 108(23):759-63. PubMed ID: 9092208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biological aspects of Creutzfeldt-Jakob disease related to the extractive growth hormone].
    Deslys JP
    Pathol Biol (Paris); 1995 Feb; 43(2):97-103. PubMed ID: 7777386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Creutzfeldt-Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine.
    Martínez-Lage JF; Rábano A; Bermejo J; Martínez Pérez M; Guerrero MC; Contreras MA; Lunar A
    Surg Neurol; 2005 Dec; 64(6):542-5, discussion 545. PubMed ID: 16293480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Norrby E
    Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.